CTJHY yields 7.53% · PFE yields 6.13%● Live data
📍 CTJHY pulled ahead of the other in Year 1
Combined, CTJHY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CTJHY + PFE for your $10,000?
CITIC Resources Holdings Limited, an investment holding company, engages in the exploration, development, and production of oil and coal. The company operates through four segments: Aluminum Smelting, Coal, Import and Export of Commodities, and Crude Oil. The Aluminum smelting segment operates a Portland aluminum smelter, which sources alumina and produces aluminum ingots in Australia. The Coal segment mines and sells coal in Australia. The Import and Export of Commodities segment exports various commodity products, such as aluminum ingots, alumina, and copper; and imports other commodities and manufactured goods, including steel, vehicle and industrial batteries, and tyres in Australia. The Crude Oil segment explores, develops, and operates oilfields, as well as sells oil in Indonesia and China. It also engages in financing; oil technology development; and property holding activities, as well as provides consulting and management services. The company was incorporated in 1997 and is headquartered in Kowloon, Hong Kong. CITIC Resources Holdings Limited is a subsidiary of CITIC Group Corporation.
Full CTJHY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.